Nabla, founded in 2018 in Paris by Alexandre Lebrun, Delphine Groll, and Martin Raison, builds an ambient AI medical scribe listening to patient-clinician conversations and generating structured clinical notes, competing directly with Abridge, Ambience Healthcare, and Suki AI, all also covered in this directory.
The company reached more than 85,000 clinicians across over 150 healthcare organizations, processing more than 20 million patient encounters annually, and raised a $70 million round led by HV Capital in 2025, bringing total funding to $120 million from investors including Highland Europe and Cathay Innovation.
Pricing runs more accessibly than several US-headquartered competitors, with a Starter tier around $119 a month and a Pro tier around $239 a month per provider. For a clinician or smaller practice that wants ambient documentation priced more accessibly than enterprise-focused US competitors, Nabla's pricing structure addresses that directly.
